17.06.2021 Views

Gastroenterology Today Summer 2021

Gastroenterology Today Summer 2021

Gastroenterology Today Summer 2021

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CASE REPORT<br />

of toxicity. Clinical manifestations of lead toxicity are varied and can<br />

be non-specific. Acute toxicity often manifests as abdominal pain,<br />

constipation, body pains, decreased libido, headaches, memory<br />

problems and irritability. Chronic exposure can produce anaemia,<br />

reduced neuro-cognitive function, nephropathy, tremor, hearing loss<br />

and hypertension 2 .<br />

In the paediatric population lead toxicity risks significant and<br />

irreversible neurodevelopmental damage and should be investigated<br />

in any child presenting with an unexplained alteration in mental<br />

state and behavioral changes in the presence of risk factors for lead<br />

exposure 3 .<br />

An elevated blood lead level reflects recent exogenous exposure as<br />

well as release of endogenous lead from bone and soft tissue stores.<br />

Toxicity is thought to develop due to lead competing with calcium in<br />

several biological processes, inhibiting enzymes, and altering the<br />

permeability of the blood brain barrier.<br />

The mainstay of management is the separation of the patient from<br />

the source of the lead exposure. In patient with very elevated lead<br />

levels (>50 mcg/dL) or symptoms of acute toxicity chelation therapy<br />

can be considered under specialist guidance 4,5 . The two most<br />

commonly used chelating agents are DMSA (2,3-dimercaptosuccinic<br />

acid) or EDTA (calcium disodium ethylenediaminetetraacetic acid).<br />

Chelation should not be undertaken unless exposure to lead has<br />

been curtailed, as in the presence of ongoing lead exposure,<br />

chelation may lead to enhanced absorption of lead and therefore<br />

worsening toxicity.<br />

Regular and long-term monitoring of lead levels is required until<br />

normal levels are achieved, as lead can be stored in bone for several<br />

decades. Patients with established sequelae of lead toxicity such as<br />

cardiovascular disease, cognitive dysfunction and renal failure are<br />

unlikely to see reversibility of their symptoms over time even with<br />

chelation therapy.<br />

Conclusion<br />

Lead toxicity is an uncommon yet important differential in patients<br />

presenting with persistent abdominal pain. Prompt diagnosis and<br />

subsequent treatment is imperative in negating the potentially long-term<br />

damaging effects of lead on multiple organ systems. In these patients,<br />

a through social history is the most crucial, but often overlooked, step in<br />

reaching the diagnosis.<br />

References<br />

1. J. Route Reigart, British Medical Journal Best Practice<br />

Guidelines; Approach to Lead Toxicity. Updated 17th April <strong>2021</strong>.<br />

https://bestpractice.bmj.com/topics/en-gb/755/diagnosisapproach#referencePop27<br />

2. National Toxicology Program. Health effects of low-level lead<br />

evaluation. Research Triangle Park, NC: US Department of Health<br />

and Human Services; 2012. http://ntp.niehs.nih.gov/pubhealth/hat/<br />

noms/lead/index.html<br />

3. D. A. Gildow, Lead Toxicity, Occupational Medicine 2004;54:76–81<br />

DOI: 10.1093/occmed/kqh019<br />

4. Lin JL, Ho HH, Yu CC. Chelation therapy for patients with<br />

elevated body lead burden and progressive renal insufficiency. A<br />

randomized, controlled trial. Ann Intern Med 1999; 130:7.<br />

5. Association of Occupational and Environmental Clinics. Medical<br />

management guidelines for lead-exposed adults. April 2007. http://<br />

www.aoec.org<br />

6. Centres for Disease Control (CDC) and Prevention. Adult blood lead<br />

epidemiology and surveillance (ABLES). http://www.cdc.gov/niosh/<br />

topics/ables/description.html<br />

Table 1: Risk Factors for Lead Exposure 1<br />

Age<br />

Pica syndrome<br />

Housing environment<br />

Occupation<br />

Recreational activities<br />

Traditional / herbal medicines<br />

Children between the ages of 9-36 months are at the most risk of ingesting lead-containing substances in<br />

their environment.<br />

Compulsive ingestion of material with no nutritional value. Most commonly seen in children and pregnant<br />

women.<br />

Older homes (built before 1970) may have lead piping or lead paint.<br />

Any job that involves handling material that may include lead, especially construction and decorating. The<br />

risk is increased if the job entails sanding down walls or removing paint which generates a fine dust of lead<br />

particles that are easily inhaled and ingested.<br />

Including painting, figurine or jewelry making and stained glass making.<br />

Any herbal remedy may contain lead. Most common sources are Ba- baw-san (traditional Chinese remedy<br />

for colic), Daw Tway (used in Thailand and Burma as a digestive aid), Greta (traditional Hispanic remedy<br />

for digestion or used during teething) and Ghasard (Indian folk medicine used as a tonic)<br />

GASTROENTEROLOGY TODAY - SUMMER <strong>2021</strong><br />

21

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!